UNDERSTAND PHAGE

What are phages?

Phages are older than human life and a natural biological agent that is abundant throughout our planet. Bacteriophages, commonly known as phages, are viruses that infect and subsequently replicate inside bacterial cells. They are different to antibiotics, and have huge potential to help in the fight against antimicrobial resistance.

Phages have been used in the frontline of human and animal health in some parts of the world for decades.

Read these articles to understand more:

1. Phage therapy outcomes for 100 consecutive cases (Nature)

This work reveals 77% of patients clinically improved in a Belgian case series of 100 after being treated with phage therapy for severe and difficult–to–treat infections. 

2. Phages: The next trillion dollar idea in biotech (Forbes)

This article explains why phages have been left behind until now, their extensive applications beyond human infections, and just how investible they are. 

3. The antimicrobial potential of bacteriophages (UK Government)

This UK select committee report from 2024 supports a vision for the production and clinical use of phages in humans and touts the technology as a “trailblazer” for personalised medicine.   

4. Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review (Lancet Infectious Diseases).

This deep work details evidence from 59 clinical studies expertly screened from over 10,000 and concludes that phage treatment is safe and effective. 

5. Ethical argument for establishing good manufacturing practice for phage therapy in the UK (BMJ – Journal of Medical Ethics)

This article supports the application manufacturing standards for onshore manufacturing of UK phages.

6. Enzyme-Linked Phage Receptor Binding Protein Assays Enable Identification of Bacillus anthracis Colonies (Viruses)

This is one example of the many applications of phage technology; biosecurity. Here they are shown to enable the detection of the bio-weapon anthrax. 

PHACTS

Phages are the viruses of bacteria. They are incredibly small and are the most common organisms on Earth.

They self-replicate and multiply to the levels needed in the body meaning we do not need to dose them like we do for other pharmaceuticals.



Why phage therapy?

The UK lags behind other countries in terms of access to phages for end-stage infections. It currently takes a clinician 200 hours to navigate the regulatory burden and secure an imported treatment from Europe. The process is convoluted and time consuming for clinicians whilst patients sit in a critical state on the edge of life & death.

Find our more about political and regulatory challenges by clicking on Phage Politico below.

PHAGE POLITICO

Policy & more

CITIZEN PHAGE LIBRARY

Developing therapeutic phages to fight antimicrobial resistance with Citizen Science.

Get in touch with Phage CoLab

    Full name *

    Email address *

    Organisation *

    Role *

    Phone number *

    I would like to: *

    Type your message here... *

    Fields marked with (*) are mandatory. By submitting this message, you agree with our Privacy Policy.

    Phage CoLab
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Please see our privacy policy for more.